Long-acting fusion interferon for dogs and cats, as well as preparation method and application thereof

An interferon, fusion protein technology, applied in biochemical equipment and methods, chemical instruments and methods, microorganism-based methods, etc., can solve complex problems, reduce product costs, improve therapeutic effects, and improve biological activity. Effect

Active Publication Date: 2015-03-18
CHANGCHUN SR BIOLOGICAL TECH
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the use of fusion proteins of INFα and HSA is extremely complicated. How to design the structure of the fusion protein so that both can maintain relatively independent biological activities; how to construct a high-expression strain and separate and prepare a high-purity fusion protein. Fusion protein structure and biological function identification need to be fully studied
At present, there is no method of prolonging the half-life of interferon by fusion protein in the application of interferon in dogs and cats

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Long-acting fusion interferon for dogs and cats, as well as preparation method and application thereof
  • Long-acting fusion interferon for dogs and cats, as well as preparation method and application thereof
  • Long-acting fusion interferon for dogs and cats, as well as preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] The preparation of embodiment 1 dog, cat long-acting fusion interferon

[0028] The recombinant canine and feline serum albumin-interferon fusion protein expression vectors were constructed with CSA, FSA, cIFN and fIFN respectively.

[0029] The preparation steps of dog and cat serum albumin-interferon fusion protein:

[0030] 1. Design primers with reference to the open reading frame of canine serum albumin (CSA) gene (NM_001003026.1), cat serum albumin (FSA) gene (NM_001009961.1) and the physical map of yeast expression vector pPIC3.5k and introduce restriction sites During this period, the natural signal peptide of serum albumin is retained, the stop codon of serum albumin is removed, and the signal peptide and initiation codon of interferon are removed.

[0031] (1) CSA upstream primer:

[0032] CSA1:

[0033] 5`-GC GAATTC GCCATGAAGTGGGTAACTTTTATTTCCCTCTTCTTTC-3`, of which the 5` end contains an EcoRI enzyme cleavage site;

[0034] CSA downstream primers:

[...

Embodiment 2

[0080] The activity detection of embodiment 2 dog, cat long-acting fusion interferon

[0081] 1. Detection of biological activity in vitro: WISH-VSV micro cytopathic inhibition method was used to detect the biological activity of long-acting fusion interferon in dogs and cats in vitro, and the cells were counted as 2.5×105~3.5×105 cells / ml of WISH cell suspension Seed in 96-well cell plate, 100 μl per well, 37°C, 5% CO 2 Cultivate under conditions for 4-6 hours. Prepare complete culture medium: 10% bovine serum MEM, assay medium: 7% bovine serum MEM, challenge medium: 3% bovine serum MEM. Dilute the standard sample to 103IU / ml with the measurement culture medium, then dilute the standard sample dilution and the induction culture supernatant to be tested 4 times, and dilute to 412 times. Add the doubly diluted positive control standard and the induced culture supernatant to be tested into the 96-well plate that has been plated with WISH cells according to the concentration gr...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a fusion protein consisting of serum albumin of dogs and cats and interferon. The amino acid sequence of the fusion protein is shown as SEQ ID No.1 or 2. The long-acting fusion interferon for dogs and cats can be used for prolonging the half life of interferon, improving the biological activity of the interferon in an organism body, and reducing the cost of interferon medical preparation, and can be applied to prevention and treatment of diseases of dogs, cats and other animals.

Description

technical field [0001] The invention relates to the technical field of animal disease prevention and treatment, in particular to a long-acting fusion interferon for dogs and cats and a preparation method and application thereof. Background technique [0002] Interferon (IFN) is a class of important cytokines, which are secreted glycoproteins produced by biological cells under the action of virus or other heterologous substance inducers. It has a variety of biological effects and has a good therapeutic effect on viral diseases, bacterial diseases, tumors and other diseases. However, interferon has a short half-life in clinical applications and is easily degraded in the body. These problems limit the full play of interferon's biological effects and directly affect the effective application of interferon in clinic. Therefore, how to prolong the half-life of interferon and improve the interference The effect of the biological activity of the hormone has become the focus of rese...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07K19/00C12N15/62C12N15/81C12N1/19A61K38/21A61K47/48A61P35/00A61P31/12C12R1/84
Inventor 夏振强郑文文夏晓红段旖金宏丽王照黄靖陈宪平付玉
Owner CHANGCHUN SR BIOLOGICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products